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ABSTRACT
β-Glucan in oat is widely considered as the main ingredient for the anti-hypercholesterol effects; however, phenolic compounds
in oat are also regarded to possess potential activities against dyslipidemia. In order to understand the underlying mechanisms thoroughly, it is of great significance to evaluate and compare the hypolipidemic properties exerted by oat phenol-rich extract (PE) and
β-glucan extract (GE) in hyperlipidemic ICR mice induced by high-fat diet. The study was conducted for 12 weeks. Both PE and GE
showed a significant hypocholesterolemic action by reducing the concentration of serum total cholesterol (TC), low density lipoprotein cholesterol and hepatic TC. Only PE reduced the hepatic triacylglycerol (TG), inhibited hepatic 3-hydroxy-3-methylglutary CoA
reductase activities and improved the hepatic antioxidant defense system. However, GE significantly increased fecal excretion of
neutral cholesterol and bile acids. This study demonstrated that not only β-glucan but also oat phenolic acids contributed to a preventive effect on hyperlipidemia. Based on the cholesterol metabolism and antioxidant defense system, the effects of the two functional
components of oat were exerted in different ways.
Key words: Oat, β-glucan, Phenolic acids, Hyperlipidemia, HMG-CoA reductase

Introduction
Hyperlipidemia, resulted from the metabolic changes
of lipid, is a major cause of atherosclerosis and atherosclerosis-associated conditions, such as coronary heart
diseases (CHD), ischemic cerebrovascular diseases and
peripheral vascular diseases. The control of serum cholesterol or low density lipoprotein (LDL) levels through nonpharmacological treatments or drug administration has
been shown to reduce the risk of CHD (1).
Results of several studies showed that oat and oat
bran contained factors which could reduce the levels of
serum total cholesterol (TC) and low density lipoproteincholesterol (LDL-C) both in animals and humans(2-4). The
Food and Drug Administration of the USA has approved
health claims of the benefit of using foods with oats for
CHD(5). It is accepted that the soluble fiber fraction mainly
β-glucan, is the primary functional ingredient in oat(6).
* Author for correspondence. Tel: +86-10-62737129;
Fax: +86-10-62347334; Email: zn_jibp@163.com

The most plausible cholesterol-lowering mechanism of
oat β-glucan is increasing the viscosity of the gastric and
intestinal contents, hence interfering with reabsorption of
bile acids and increasing the fecal excretion(7). In addition,
oat contains a wide range of phenolic compounds(8). A
number of studies have identified the phenolic compounds
in oats, such as ferulic acid, caffeic acid, p-coumaric acid,
sinapic acid, vanillic, and syringic(9-11). Collins isolated
and characterized a group of low molecular weight soluble
phenolic compounds, named avenanthramides (AVEN),
which are not present in other cereal grains(12). These oat
phenolics exhibit antioxidant capacity both in vitro and
in vivo(13-15). Chen found oat phenolics inhibited LDL
oxidation in vivo, so being potential to prevent the important first stage in the development of atherosclerosis(15).
Recently studies have reported the antiatherogenic potential of AVEN through inhibition of adhesion of monocytes to human aortic endothelial cell monolayers and
serum-induced proliferation of vascular smooth muscle
proliferation, both of which are important processes in the
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initiation and development of atherosclerosis(16,17). Among
various plant phenolic compounds, those from plant foods,
such as tea, red wine and olive oil were reported to regulate the lipids metabolism in vivo(18-20). Similar to their
actions in other foods, simple phenolic acids and polyphenolics from oats may serve as potential functional components on the prevention of hyperlipidemia.
To date, few studies have explored directly the function of oat phenolic compounds for hyperlipidemia and
atherosclerosis in vivo, and the comparison of the beneficial effects of oat β-glucan and oat antioxidants in vivo is
still lack. Therefore, to fill this knowledge gap, this study
was conducted with the following goals: 1) to investigate
the effects of phenolic compounds extracted from oat
in high-fat diet-induced hyperlipidemic ICR mice; 2)
to compare the prevention function and mechanism of
β-glucan and oat phenolic compounds for hyperlipidemia
from the aspects of cholesterol metabolism and antioxidant defense system.

MaterialS and methods

Folin-Ciocalteu method (23) was used to measure the
total phenolic content with a UV-visible spectrometer
(GBC scientific equipment Pty Ltd, Australia). The total
polyphenolic content in the oat phenol-rich powder was
35.2 mg (207 μmol) gallic acid equivalents/g.
II. Animals and Treatment
Forty 6-week-old male ICR mice (Experiment
Animal Center of Beijing) were fed for 12 weeks after
acclimatization for 7 days. Animals were allocated five
per polycarbonate cage in a temperature（23 ± 1°C）and
humidity (55 ± 5%) controlled room, with 12-hr light
and dark cycles. The ICR mice were randomly divided
into four groups: normal diet group (ND), high-fat diet
(HFD) group, β-glucan extract (GE) treatment group,
and phenol-rich extraction (PE) treatment group. The ND
mice received a commercial regular diet, the HFD group
and treatment groups were given high-fat diet (HFD)
(shown in Table 2, provided by Experiment Animal
Center of Beijing). The estimated daily polyphenolic and
β-glucan intake for a 70 kg body person is 14 mg/kg(24)

I. Preparation of Oat β-glucan and Phenol-rich Extracts
(I) β-Glucan extract (GE)
Oat was obtained from Zhangjiakou, Hebei Province,
China. β-Glucan was extracted from oat by a process of
Aman and Hesselman(21). In brief, ground oat flour was
mixed with boiling water and bacterial α-amylase to
extensively hydrolyze starch, solubilize β-glucan and
inactivate contaminating β-glucanase activities. Protease
(papain) was used to hydrolyze protein in addition to the
starch hydrolysis step. Solubilized β-glucan in the clarified liquid fraction was precipitated, washed with ethanol
and lyophilized. About 9.53 g GE was obtained from
100 g oat grounds. Analysis of the β-glucan preparation is
presented in Table 1. β-Glucan was quantified enzymatically(22) using a Megazyme β-glucan mixed linkage assay.
Protein concentration, moisture and fat concentration
were determined by AOAC methods 991.20, 926.08, and
933.05, respectively(27). Ash concentration was determined by Corn Refiners Association Standard Analytical
Method A-4(28).

Table 1. Approximate composition of β-glucan concentrates from
oats
Composition

Content (%)

Carbohydrates

81.61

β-Glucan

71.68

Protein

9.67

Moisture

5.35

Fat

1.21

Ash

2.16

Table 2. Chemical composition of fed diets (g/100 g d.w.)
Ingredients

Content
RD

CED

59

48

Protein

21.1

21.1

Fiber

4.9

4.9

(II) Phenol-rich Extract

Fat

4.2

4.2

Phenol-rich extract was prepared by the process
similar to that of Chen(15) with slight modification.
The hulless oats were ground and extracted twice with
ethanol : water (4 : 1) up to 1.0 L for 2 h at 40°C with
continuous agitation. After cooling, the extraction slurry
was centrifuged at 1,250 ×g for 15 min. The supernatant
was vacuum rotary evaporated at 45°C and lyophilized to
an oat phenol-rich powder and stored at -20°C until use.
About 2.41 g PE was obtained from 100 g oat grounds.

Ash

8

8

Sodium cholic acid

–

0.2

Cholesterol

–

1

Lard

–

9.8

P

1

1

Ca

1.8

1.8

Carbohydrate

Note: RD, regular diet; CED, cholesterol-enriched diet.
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and 50 mg/kg(6), respectively, which indicated a suggested
daily intake ratio of these two compounds of 14 : 50. The
dosage for the animal models should be 10-times greater
than the human intake, due to the different metabolic rate
between mice and human. Therefore, we chose the dose
of 140 mg/kg for PE and 500 mg/kg for GE in present
study. Both extracts were delivered in distilled water and
administered at a dose of 10 mL/kg by oral gavage. Equal
volume of distilled water was given to mice in ND and
HFD groups.
The animals were given free access to diets and
distilled water throughout the experimental period.
Weight gain was measured every three days. At weeks
3, 6, 9, 12, mice were fasted overnight (12 hr), blood
samples from mice were obtained by peri-orbital
bleeding and centrifuged at 3,000 rpm for 8 min under
room temperature and stored at -20°C for future analysis.
Feces were collected during the last 3 days using metabolic cages and used for determination of the fecal sterol
and bile acids. At the end of the experiment period and
blood sampling, the animals were sacrificed by cervical
dislocation. The livers were excised, weighed and stored
at -80°C until analysis.
III. Serum and Hepatic Lipids
Serum lipid parameters, including TC, triacylglycerol (TG), LDL-C, and high density lipoproteincholesterol (HDL-C) were assayed individually using
the enzymatic kits (Beijing Zhongsheng Hightech
Bioengineering Company, Beijing, China) on an Alcyon
300 auto-analyzer (Abbott Laboratories Ltd., US). The
atherogenic index (AI) was calculated as (TC-HDL-C) /
HDL-C. Hepatic lipids were extracted from 300 mg
liver of a mouse with chloroform : methanol (2 : 1, v/v),
according to the method of Folch et al(25). After extraction, 1 mL of extract was dried under nitrogen stream.
The dried lipid residues were dissolved in 500 μL distilled
water by sonication for 5 min. Triton X-100 was added to
the dissolved lipid solution to produce final concentration
of 5 g/L. The hepatic TC and TG were analyzed with the
same enzymatic kits as above in the serum analysis.
IV. Hepatic Antioxidant Indices
The total antioxidant capacity (TAC), superoxide
dismutase (SOD) activity and malondialdehyde (MDA)
concentration were determined in liver homogenates
with commercial kits obtained from Nanjing Jiancheng
Bioengineering Institute (Nanjing, China). TAC was
measured by the reaction of phenanthroline and Fe2+ in
a spectrophotometer at 520 nm and a TAC unit is defined
as the amount of antioxidants required to make the absorbance increase 0.01 in 1 mL serum. For SOD measurement, superoxide radicals were generated by NADPH and
PMS (phenazine methosulfate) under non-acidic conditions which reduces NBT (nitroblue tetrazolium salt)

and forms a blue coloured formazon whose absorbance
can be measured at 560 nm. Free radical damage was
determined by specially measuring MDA. MDA formed
as an end product of lipid peroxidation was treated with
thiobarbituric acid to generate a colored product that was
measured at 532 nm.
V. Hepatic 3-hydroxy-3-methylglutary CoA (HMG-CoA)
Reductase Activities
The activity of HMG-CoA reductase in mice was
determined by the method of Edwards et al(26). The
isolated liver microsomes were mixed with an equal
volume of 50% glycerol in phosphate buffer (0.1 M
sucrose, 0.05 M KCl, 0.04 M potasium phosphate, 0.03 M
potassium EDTA and 10 mM DTT, pH 7.2). The mixture
was homogenized and incubated at 37°C for 60 min to
solubilize HMG.-CoA reductase. The activity of the
solubilized HMG-CoA reductase was assayed in phosphate buffer (0.2 M KCl, 0.16 M potassium phosphate,
0.004 M EDTA, and 0.01 DTT, pH 6.8) together with
0.2 mM NADPH and 0.1 mM RS-HMG-CoA at 37°C in
a spectrophotometer. The results were expressed as nmol
mevalonate synthesized per min per mg protein.
VI. Determination of Fecal Neutral Cholesterol and Bile
Acids
Fecal samples (0.2 g) were homogenized with 2 mL
of a mixture of 10 M NaOH and 96% ethanol (1 : 2, v/v)
and kept at 70°C for 45 min. The samples were allowed
to cool to room temperature followed by centrifugation
at 1,000 ×g for 5 min. The supernatant was removed and
extracted with n-hexane twice. The combined hexane
phases were washed with 70% ethanol until neutral for
neutral cholesterol analysis; the lower phases were acidified with HCl and extracted with chloroform:methanol
(2 : 1, v/v) for bile acids analysis. The cholesterol and
coprostanol was analyzed using a Shimadzu (Shimadzu,
Kyoto, Japan) GC-14 gas chromatography system
equipped with a flame ionization detector and a 30 m ×
0.25 mm DM-5 capillary column maintained at 290°C
using nitrogen gas as carrier. The initial column temperature was 220°C and was elevated to 300°C at a rate of
2°C/min. The final temperature was held for 10 min. The
flow rate was 1.5 mL/min. Pure cholesterol and coprostanol (Sigma-Aldrich, St. Louis, MO) were used as standards. Total neutral cholesterol was expressed as percent
of total fecal cholesterol plus coprostanol. Fecal acidic
steroids were determined using an enzymatic kit (Total
Bile Acid Kit, Wako, Japan).
VII. Statistical Analysis
Data are presented as means ± standard deviation
(SD). SPSS 13.0 for Windows (SPSS Inc., Chicago, IL)
was used to analyze the variance homogeneity (one-way
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ANOVA analysis). Means were compared using the
Duncan test at the 95% significance level.

Results

II. Serum Lipids and Atherogenic Index Profiles

I. Body Growth and Organ Weights
Weight gains and relative organ weights are listed
in Table 3. Although there was no significant difference
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Table 3. Body weight gain and liver weight (g/body weight) in control and treatment groups
Body weight

Treatment

Liver weight

Initial (g)

Final (g)

Weight gain (g)

Total (g)

g/100 g body weight

ND

26.38 ± 2.00

35.61 ± 5.69

9.65 ± 5.16

1.41 ± 0.25a

3.95 ± 0.18a

HFD

26.30 ± 1.83

38.26 ± 2.25

11.81 ± 1.93

1.62 ± 0.10b

4.23 ± 0.08b

GE

26.31 ± 1.52

38.82 ± 4.95

12.51 ± 3.72

1.59 ± 0.21ab

4.10 ± 0.22ab

PE

26.31 ± 1.48

37.49 ± 2.80

11.47 ± 2.68

1.48 ± 0.15ab

3.96 ± 0.22a

* N D, normal diet group; HFD, high-fat diet group; GE, β-glucan extract treatment group; PE, phenol-rich extract treatment group. Data are
presented as mean ± SD (n = 10). Values in a line with different superscript are significant different at p < 0.05.

Table 4. Hepatic lipid profile in each group
Hepatic lipid

ND

HFD

GE

PE

Cholesterol (μmol/g liver)

5.50 ± 1.23a

18.6 ± 1.59c

12.90 ± 1.34b

13.53 ± 2.27b

Triacylglycerol (μmol/g liver)

44.97 ± 3.25a

71.77 ± 6.93c

72.57 ± 6.58c

52.93 ± 7.36b

* N D, normal diet group; HFD, high-fat diet group; GE, β-glucan extract treatment group; PE, phenol-rich extract treatment group. Data are
presented as mean ± SD (n = 10). Values in a row with different superscript are significant different at p < 0.05.

this experiment. Compared with HFD group, serum TC
content in GE and PE significantly ( p < 0.05) reduced
by 33.9% and 33.5% at the end of experiment (week 12),
respectively; yet no significant difference was observed
between GE and PE group.
No difference was observed in serum TG levels
across all groups at week 3 and 6. Subsequently, at week
9 and 12, serum TG levels in HFD group significantly
( p < 0.05) decreased to 77.42% and 56.35% of ND group,
respectively. The serum TG levels in both GE and PE
group decreased significantly ( p < 0.05), though mild,
as compared with HFD group. TG levels for GE and PE
groups increased to 87.63%, 89.25% and 65.99%, 73.10%
of ND group at week 9 and 12, respectively. A significant
increase of serum LDL-C levels as 118.18% was detected
in HFD group compared with ND group. Dramatic
decreases of LDL-C levels were observed in both GE
and PE group compared with HFD group. PE group had
a better ( p < 0.05) LDL-C lowering effect than GE group
at the beginning of the experiment, with reduction to
82.05% vs. 64.1% of HFD group at week 3. However, at
the end of the experiment, PE and GE reduced LDL-C
to the similar level. Although the HDL-C level did
not differ significantly across groups during the first 6
weeks, 28.16% increase of serum HDL-C was detected
at the end of the experiment (week 12) in HFD group
compared with ND group ( p < 0.05). Neither GE nor PE
group showed HDL-C-elevating effects compared with
HFD group. GE and PE group significantly ( p < 0.05)
decreased AI by 55.1% and 48.0% respectively compared
with HFD group.

III. Hepatic lipid profiles
Data are listed in Table 4. Hepatic TC and TG levels
were significantly ( p < 0.05) elevated by HFD. However,
TC contents in GE and PE group significantly ( p < 0.05)
decreased in the whole liver by 30.65% and 27.30%,
respectively. TG levels did not differ significantly
between GE and HFD group, but it decreased significantly ( p < 0.05) in PE group by 26.3% compared with
HFD group.
IV. Hepatic TAC, SOD Activity and MDA Levels
The profile of antioxidative status is presented in
Table 5. There was a decrease in the activities of hepatic
TAC and SOD ( p < 0.05) in HFD group compared with
ND group. Administration of PE brought about a significant improvement ( p < 0.05) in antioxidant defenses
of HFD-fed mice, and GE seemed to have no effect on
TAC and SOD. Hepatic MDA levels increased significantly in the HFD group compared with ND group.
Administration of PE restored MDA concentration to
ND levels significantly ( p < 0.05), while GE group failed
to diminish lipid peroxidation, showing MDA values
similar to that of HFD group.
V. Hepatic HMG-CoA Reductase Activities
Compared with ND group, hepatic HMG-CoA
reductase activity was decreased in HFD group (Table
5). Administration of PE slightly ( p < 0.05) decreased
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Table 5. Hepatic antioxidant status and HMG-CoA reductase activit
ND

HFD

GE

PE

TAC (U/mg protein)

1.91 ± 0.18a

1.03 ± 0.19c

1.00 ± 0.11c

1.44 ± 0.08b

SOD (U/mg protein)

175.09 ± 0.53a

77.89 ± 5.90c

94.03 ± 6.50c

118.36 ± 6.90b

MDA (nmol/mg protein)

0.75 ± 0.07a

1.54 ± 0.09c

1.52 ± 0.06c

0.96 ± 0.06b

Hepatic HMG-CoA reductase
(nmol/min/mg protein)

6.71 ± 0.18a

5.37 ± 0.33c

5.05 ± 0.33bc

4.77 ± 0.28b

Hepatic antioxidant status

* N D, normal diet group; HFD, high-fat diet group; GE, β-glucan extract treatment group; PE, phenol-rich extract (PE) treatment group;
TAC, total antioxidant capacity; SOD, superoxide dismutase; MDA, malondialdehyde; HMG-CoA, 3-hydroxy-3-methylglutary CoA
reductase. Data are presented as mean ± SD (n = 10). Values in a row with different superscript are significant different at p < 0.05.

Table 6. Fecal neutral sterol and total bile acids concentrations in each group
Components

ND

HFD

GE

PE

Cholesterol

0.20 ± 0.03a

0.97 ± 0.05b

1.24 ± 0.10c

0.95 ± 0.08b

Coprostanol

0.52 ± 0.07a

1.30 ± 0.25b

2.62 ± 0.35c

1.41 ± 0.24b

Total

0.72 ± 0.06a

2.27 ± 0.26b

3.86 ± 0.40c

2.36 ± 0.35b

Total bile acids (mg/d)

0.48 ± 0.03a

1.51 ± 0.10b

1.89 ± 0.12c

1.54 ± 0.10b

Neutral steroids (mg/d)

* N D, normal diet group; HFD, high-fat diet control group; GE, β-glucan extract treatment group; PE, phenol-rich extract treatment group.
Data are presented as mean ± SD (n = 10). Means within the same row without a common letter differ significantly at p < 0.05.

HMG-CoA reductase activity compared with HFD group,
but GE group did not modify its activity significantly.
VI. Fecal Excretion of Neutral Cholesterol and Bile Acids
Fecal neutral sterol and total bile acids excretion data
are shown in Table 6. HFD group excreted significantly
more fecal neutral sterols and total bile acids than ND
group. Compared with HFD group, GE group significantly
increased fecal sterol and bile acids excretion by 58.0%
and 25.2%, but PE group did not show such an effect.

Discussion
High serum TC and LDL-C are the main risk
factors in the pathogenesis of CHD (1). The results of
this investigation showed that HFD intake led to an
increase of cholesterol content both in serum and liver.
In our study, serum HDL-C levels increased significantly in HFD group compared with ND group too. This
HDL-C elevating effect in hyperlipidemic ICR mice
may result from the stress reaction caused by high-fat
diet in vivo, and similar observations were also reported

in other researches (30-35) . Both PE and GE had a distinct
cholesterol-lowering effect by decreasing serum TC,
serum LDL-C and hepatic TC, accordingly reducing
the risk of CHD. Similar cholesterol-lowering results
have been previously reported in β-glucan(3,4) and many
polyphenols from different plant foods(18-20). For serum
LDL-C at the beginning of the experiment, oat phenolic
compounds may have a better LDL-C-lowering effect
than β-glucan in the initial stage of hyperlipidemia; but
for long term, their modification on LDL-C are similar.
AI (TC-HDL)/HDL) has direct correlation with the
cardiovascular disease. Both PE and GE were able to
decrease AI significantly, contributing to the low risk in
pathology of hyperlipidemia and atherosclerosis.
The rise in cholesterol in liver and serum may be
due to increased uptake of exogenous cholesterol and
subsequent deposition and decreased catabolism of
cholesterol to bile acids(36). To elucidate the mechanism
of the TC-lowering action of PE and GE, we examined
the hepatic HMG-CoA reductase activity and fecal
cholesterol and bile acids excretion. HMG-CoA reductase
is the rate-limiting enzyme in the cholesterol biosynthetic pathway. The inhibition of HMG-CoA reductase
suppresses cholesterol synthesis and is very effective
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in lowering serum cholesterol(37). High cholesterol diet
itself inhibited HMG-CoA reductase activity in our
study for the feedback regulation of cholesterol, which
was also illustrated by Hayashi et al(38). Previous studies
demonstrated that polyphenols extract from virgin olive
oils(20) and naringenin(39), a kind of phenolic compound,
suppresses HMG-CoA reductase activity in liver microsome. Similarly, PE group significantly reduced the
activity of HMG-CoA reductase compared with HFD
group, suggesting the hypocholesterolemic effects of oat
phenolic compounds by suppressing the rate of cholesterol synthesis. Although β-glucan might be subjected
to microbial degradation in the lower gut to propionic
acid, an inhibitor of HMG-CoA reductase (40), GE group
was observed to have no obvious effect on HMG-CoA
reductase. However, GE group enhanced the excretion of
neutral steroids and bile acids, indicating the hypocholesterolemic effect of GE by decreasing intestinal cholesterol
absorption and bile acids reabsorption for its viscosity
property as reported in oat bran and dietary fiber (7,41).
Accelerated rate of catabolism of cholesterol to bile acids
is also related to enhance fecal bile acids excretion, which
would be another mechanism of the hypocholesterolemic
effect of GE, but further study is needed to prove it.
Several reports have demonstrated increased serum
TG by HFD(29); however, in this study HFD reduced
serum TG content in the end of the experiment, associating with an increase in hepatic TG. This observation
was accordant with the previous research by Pan et al.(42),
who proved that high-fat diet containing cholesterol and
bile salt (called as cholic acid in current study) could
contribute to the imbalanced serum TG level in ICR mice.
In current study, the high-fat diet contained both cholic
acid and cholesterol (Table 2). Also, our lab has recently
tested the hypothesis that the reduction of serum TG is
associated with the elevation of hepatic TG, resulting in
ectopic accumulation in liver and leading to the progression of fatter liver and hepatic steatosis (32,34). Hepatic
TG content is regulated by TG biosynthesis, lipoprotein
secretion to the bloodstream, and degradation of fatty
acid by β-oxidation(43). It was reported that dietary
cholesterol reduced the rate of fatty acid oxidation and
increased the rate of TG biosynthesis in rats (44). In some
hyperlipidemic animal models with elevated serum TG,
phenol-rich extracts(45) and β-glucan from barley(46)
can regulate the serum TG level by decreasing it. Our
research suggested that oat PE and GE might have the
potential to dual regulate the imbalanced serum TG level
by increasing serum TG levels approaching the normal
levels. PE was also beneficial to decrease TG level in liver
with lower relative liver weights. However, GE showed
no effect on hepatic TG. It has been reported that many
plant phenolic compounds such as sesamin(47), tea catechin(48), and citrus flavonoids(49) increased the hepatic
fatty acid oxidation in experiment animals, the alteration
of which is a crucial factor to the modification of serum
and hepatic lipid levels(50). It is possible that oat phenolic

compounds could regulate the hepatic fatty acid oxidation and thus significantly affect the hepatic TG level.
Further research on this mechanism is still in progress.
Oxidative stress is one of the causative factors that
link hyperlipidemia with the pathogenesis of atherosclerosis(51). Thereby it is of great importance to evaluate
the antioxidant defense system in vivo. Although early
studies demonstrated the in vivo antioxidant effects of
oat products in different animal models, they all focused
on β-glucan of the oat product (3,4,52,53) instead of other
functional components. Oat phenolics have been proved
to scavenge free radicals and reduce LDL oxidation in
vitro (13,14). Based on this study, administration of PE
prevented buildup of oxidative stress by restoring enzymatic antioxidant SOD activities and TAC in liver, as
well as inhibiting the augmentation of hepatic MDA. It
is evident that PE exerts great antioxidant effects in vivo.
Whereas, GE had no effect on liver TAC, SOD activity
and MDA level, suggesting that oat phenolic compounds
might contribute to enhance the oxidation resistance in
hyperlipidemic mice.

ConclusionS
Both oat β-glucan and phenolic compounds have
positive effects on the prevention of hyperlipidemia by
improving serum and hepatic lipids profile. Oat phenolic
compounds possess a more significant effect on attenuating hepatic oxidative stress than β-glucan. β-glucan
and phenolic compounds demonstrate different effects on
cholesterol metabolism pathway, i.e., promoting cholesterol catabolism rate and suppressing biosynthesis rate,
respectively.
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